Table 3.
Effect of PAMG (prospective vs. retrospective) on acute asthma management in ED (N = 309).
Asthma Management in ED | Unadjusted | Adjusteda | ||||
---|---|---|---|---|---|---|
Logistic Regression | ORb | 95% CI | p-value | OR | 95% CI | p-value |
Systematic corticosteroids given in ED | 3.11 | 1.82–5.30 | <0.0001 | 2.26 | 1.63–3.14 | < 0.0001 |
SaO2 reassessed before discharge | 2.14 | 1.34–3.42 | 0.0016 | 2.02 | 1.45–2.82 | < 0.0001 |
Linear Regression | βc | 95% CI | p-value | β | 95% CI | p-value |
Number of salbutamol doses given in first hour | 0.22 | 0.07–0.37 | 0.0410 | 0.23 | 0.03–0.44 | 0.0283 |
CI: confidence intervals.
All models were adjusted for the propensity score (or conditional probability) of a patient being selected for each treatment, given the pre-treatment characteristics including age, gender, history of ED visit/hospitalization for asthma, presence of wheeze, use of accessory muscles, SaO2 at initial presentation, length of stay, season of ED visit, day of ED visit, and hour of ED visit.
OR: Odds ratio (prospective versus retrospective group) was estimated using logistic regression.
Regression coefficient β (prospective versus retrospective group) was estimated using linear regression. β equals the average increase in the number of salbutamol doses in the prospective group.